Novoray (SHSE:688300) Cyclically Adjusted PS Ratio: (As of Aug. 17, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:688300 Novoray Corp SHSE:688300
80 GF Score
Price ¥166.47
GF Value ¥72.08
Valuation Significantly Overvalued
! 2 Warning Signs
View Full Analysis

What is Novoray Cyclically Adjusted PS Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Novoray  (SHSE:688300) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Novoray Cyclically Adjusted PS Ratio Related Terms


Novoray Cyclically Adjusted PS Ratio Historical Data

* Premium members only.

The historical data trend for Novoray's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Novoray Cyclically Adjusted PS Ratio Chart

Novoray Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 22.99

Novoray Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 18.34 23.63 22.99 30.29 0.00

SHSE:688300 vs LIN, SHW, ECL: Cyclically Adjusted PS Ratio Comparison

For the Specialty Chemicals subindustry, Novoray's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Novoray Cyclically Adjusted PS Ratio vs Chemicals Industry

For the Chemicals industry and Basic Materials sector, Novoray's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Novoray's Cyclically Adjusted PS Ratio falls into.


SHSE:688300
80GF Score
Novoray Corp SHSE:688300
Cyclically Adjusted PS Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Novoray Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Novoray's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2026 is calculated as:

For example, Novoray's adjusted Revenue per Share data for the three months ended in Jun. 2026 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=1.343/116.0564*116.0564
=1.343

Current CPI (Jun. 2026) = 116.0564.

Novoray Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201512 0.000 100.600 0.000
201606 0.000 101.400 0.000
201612 0.000 102.600 0.000
201703 0.276 103.200 0.310
201706 0.284 103.100 0.320
201712 0.000 104.500 0.000
201803 0.371 105.300 0.409
201806 0.402 104.900 0.445
201809 0.420 106.600 0.457
201812 0.385 106.500 0.420
201903 0.355 107.700 0.383
201906 0.455 107.700 0.490
201909 0.445 109.800 0.470
201912 0.442 111.200 0.461
202003 0.294 112.300 0.304
202006 0.416 110.400 0.437
202009 0.451 111.700 0.469
202012 0.528 111.500 0.550
202103 0.582 112.662 0.600
202106 0.614 111.769 0.638
202109 0.690 112.215 0.714
202112 0.708 113.108 0.726
202203 0.730 114.335 0.741
202206 0.733 114.558 0.743
202209 0.568 115.339 0.572
202212 0.702 115.116 0.708
202303 0.583 115.116 0.588
202306 0.710 114.558 0.719
202309 0.821 115.339 0.826
202312 0.851 114.781 0.860
202403 0.843 115.227 0.849
202406 1.006 114.781 1.017
202409 1.040 115.785 1.042
202412 1.082 114.893 1.093
202503 0.984 115.116 0.992
202506 1.150 114.907 1.162
202509 1.275 115.471 1.281
202512 1.205 115.832 1.207
202603 1.231 116.303 1.228
202606 1.343 116.056 1.343

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is Novoray (SHSE:688300) Overvalued in 2026?

Based on GuruFocus' analysis, Novoray stock appears to be overvalued. The current stock price of ¥166.47 is trading 131% above its estimated GF Value™ of ¥72.08. GuruFocus considers Novoray to be Significantly Overvalued.

Key valuation signals for SHSE:688300:

  • Cyclically Adjusted PS Ratio:
  • GF Value™: ¥72.08 vs. price of ¥166.47 (131% above fair value)
  • GF Score™: 80/100 with 2 warning signs

No single metric tells the full story. See the SHSE:688300 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Novoray Business Description

Address Xinpu Economic Development Zone, Haizhou District, Jiangsu Province, Lianyungang, CHN, 222346
Novoray Corp is engaged in the development, production and sales of silicon micro-powder products.
80GF Score

Get the complete analysis for SHSE:688300

Cyclically Adjusted PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥166.47
Price
¥72.08
GF Value